Symbol
| FUS
| contributors: mct/pgu - updated : 20-04-2017
|
HGNC name
| fused in sarcoma
|
HGNC id
| 4010
|
Other morbid association(s)
|
Type | Gene Modification | Chromosome rearrangement | Protein expression | Protein Function
|
---|
tumoral
|  
| translocation
|  
|  
|
rearranged in myxoid liposarcoma with translocation t(12;16) and in myeloid leukemia with translocation t(16;21)(q13;p11) | tumoral
| fusion
|  
|  
|  
|
fused with ATF1 in t (12;16)(q13;p11) in angiomatoid fibrous histiocytomas and with DDIT3 in myxoid liposarcoma | tumoral
| fusion
|  
|  
|  
|
fused with ERG in t(16;21)(p11;q22)in Ewing sarcoma | tumoral
| fusion
|  
|  
|  
|
with CREB3L2 in t(7;16) (q33;p11 in fibromyxoid sarcoma, low-grade | constitutional
| germinal mutation
|  
|  
|  
|
in ALS6, amyotrophic lateral sclerosis (R521G missense mutation in FUS/TLS led to aberrant trafficking with subsequent cytoplasmic retention of the mutant protein) | tumoral
|  
|  
| --over
|  
|
in liposarcoma | |
Susceptibility
|
to essential tremor |
Variant & Polymorphism
other
| nonsense mutation (c.868C>T) associated to essential tremor |
|
|
Candidate gene
Marker
Therapy target
| | | |
| major components of nuclear polyQ aggregate-interacting proteins in a Huntington disease cell model and was also associated with neuronal intranuclear inclusions of R6/2 mice |